NEW YORK — In this Healio Video Perspective from the ASRS meeting, Michael J. Allingham, MD, PhD, discusses the safety data from the ZETA-1 phase 2 clinical trial investigating Ocuphire’s APX3330 for the treatment of diabetic retinopathy.
VIDEO: APX3330 shows favorable safety profile, fewer adverse effects
NEW YORK — In this Healio Video Perspective from the ASRS meeting, Michael J. Allingham, MD, PhD, discusses the safety data from the ZETA-1 phase 2 clinical trial investigating Ocuphire’s APX3330 for the treatment of diabetic retinopathy.